Insulin Specific T and B cells in Type 1 Diabetes
1 型糖尿病中的胰岛素特异性 T 细胞和 B 细胞
基本信息
- 批准号:9180031
- 负责人:
- 金额:$ 168.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-01 至 2020-07-31
- 项目状态:已结题
- 来源:
- 关键词:AffinityAllelesAmino AcidsAntibodiesAntigensAutoantibodiesAutoantigensAutoimmune DiseasesAutoimmune ProcessAutoimmunityB-LymphocytesB-insulinBeta CellBindingBiological AssayBiological MarkersBloodBlood typing procedureCD19 geneCD4 Positive T LymphocytesCD8B1 geneCell Culture TechniquesCell LineCell SeparationCellsClinicalCytometryDevelopmentDiabetes preventionDiseaseDisease ProgressionFirst Degree RelativeFrequenciesGlycosylated hemoglobin AGoalsHLA-DQ AntigensHLA-DQ8 antigenHistocompatibility Antigens Class IIHumanImmuneImmune systemImmunoglobulinsImmunologicsImmunologyInsulinInsulin-Dependent Diabetes MellitusInterferon Type IIInterleukin-10Islet CellIslets of LangerhansKnowledgeLeadLifeLinkLongitudinal StudiesLymphocyteMaintenanceMeasuresMediatingMetabolicNatural HistoryNull LymphocytesOGTTOralOrganOrgan DonorPancreasPathogenesisPathologyPathway interactionsPatientsPeptidesPhenotypePlayPreparationPreventionPrevention trialProinsulinReceptors, Antigen, B-CellRelapseResearchResearch PersonnelRiskRoleSpecificitySpleenStaining methodStainsStudy SubjectSymptomsT cell responseT-Cell DevelopmentT-Cell ReceptorT-LymphocyteTestingTimeTissuesTranslatingadaptive immunityanergybiobankcytokinediabetes riskhigh riskhuman diseaseinsulin dependent diabetes mellitus onsetisletlymph nodesmacrophageperipheral bloodprospectivereceptorskillssubcutaneous
项目摘要
Project Summary
The adaptive immune response to islet antigens, especially proinsulin, plays a central role in type 1 diabetes
(T1D) development and pathology, with both T and B cells contributing to disease. Numerous large-scale
prevention trials, mainly using preparations of insulin (subcutaneous, oral, and intranasal) to induce tolerance
and delay the onset of clinical symptoms, have been unsuccessful. There exists the need to (1) study the
autoimmune pathogenesis within the target organ of human T1D and (2) translate immunologic phenotypes
from the islets to the blood of at risk subjects. We have recently identified proinsulin-reactive T cells from the
islets of a T1D organ donor with a specific T cell receptor (TCR) responding to insulin B chain amino acids 9-
23 presented by HLA-DQ8 when transfected into a TCR null cell line. This T cell also responds to dispersed
whole human islets, thus linking insulin B:9-23 T cell reactivity to human disease pathogenesis. Insulin B:9-23
specific CD4 T cells are present in the peripheral blood of new-onset T1D subjects. High affinity insulin-
reactive B cells are found in the peripheral blood of healthy subjects, and these cells are restricted to the
anergic B cell compartment (BND) and thus are antigen unresponsive. Importantly, in new-onset T1D patients
and some first-degree relatives (FDRs) carrying high-risk HLA alleles, these B cells lose anergy. These
findings lead us to hypothesize that insulin specific T and B cells undergo cognate interactions prior to the
development of overt disease and concentrate in the pancreatic islets and lymph nodes where they propagate
disease. This hypothesis will be tested in two specific aims. Utilizing the network for pancreatic organ donors
(nPOD), Aim 1 focuses on defining antigen specificity, phenotypes and function of islet reactive immune cells
from spleen and islets of organ donors with recent onset T1D. Aim 2 is a longitudinal study of at risk subjects
with ≥2 islet autoantibodies and HLA-DQ-DR matched autoantibody negative first degree relatives from the
TrialNet Pathway to Prevention (PTP) Living Biobank (previously referred to as the Natural History Study)
measuring functional insulin specific T cell responses, enumerating insulin binding B cells, and characterizing
insulin autoantibodies for antigen affinity and subtypes. The proposed studies will advance our long-term goal
of bridging the gap of knowledge between the target organ and blood for biomarkers of disease progression
and ultimately T1D prevention with enhanced understanding of disease pathogenesis.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John C Cambier其他文献
Src-family kinases in B-cell development and signaling
B 细胞发育和信号转导中的 Src 家族激酶
- DOI:
10.1038/sj.onc.1208075 - 发表时间:
2004-10-18 - 期刊:
- 影响因子:7.300
- 作者:
Stephen B Gauld;John C Cambier - 通讯作者:
John C Cambier
John C Cambier的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John C Cambier', 18)}}的其他基金
Autoimmunity risk alleles compromising B cell anergy
损害 B 细胞无反应性的自身免疫风险等位基因
- 批准号:
9568080 - 财政年份:2016
- 资助金额:
$ 168.89万 - 项目类别:
Autoimmunity risk alleles compromising B cell anergy
损害 B 细胞无反应性的自身免疫风险等位基因
- 批准号:
9121221 - 财政年份:2016
- 资助金额:
$ 168.89万 - 项目类别:
Mouse modeling of a human STING gene variant for infectious disease
人类 STING 基因变体感染性疾病的小鼠模型
- 批准号:
8282484 - 财政年份:2012
- 资助金额:
$ 168.89万 - 项目类别:
Mouse modeling of a human STING gene variant for infectious disease
人类 STING 基因变体感染性疾病的小鼠模型
- 批准号:
8519291 - 财政年份:2012
- 资助金额:
$ 168.89万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 168.89万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 168.89万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 168.89万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 168.89万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 168.89万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 168.89万 - 项目类别:
Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 168.89万 - 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 168.89万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 168.89万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 168.89万 - 项目类别: